Summary
This report outlines the collaborative study and in-house evaluation at NIBSC of two candidate 
Introduction
Meningococcal disease caused by serogroup A has caused a significant burden to the region of Africa stretching between Senegal and Ethiopia (named the 'African meningitis belt') for over a century [1] . In 2010 a conjugate vaccine developed specifically for the meningitis belt was introduced by the Meningitis Vaccine Project to target the periodical endemics and epidemics seen in this area. The implementation has been a success and the incidence of disease caused by and the carriage of serogroup A has declined dramatically [2, 3] . However, serogroup X, which was a rare causative agent of meningococcal disease, has emerged as a cause of outbreaks in the region since the implementation of a vaccine against serogroup A [2] . As a result of this increase in serogroup X disease there are initiatives to manufacture a conjugate vaccine similar to those used for meningococcal groups A, C, W and Y, to control disease caused by group X.
Physicochemical methods are the primary tests used to ensure batches of Neisseria meningitidis plain PS and conjugate vaccine are manufactured consistently to those shown to be safe and effective in clinical trials [4] , as well as to determine potency. In particular, determination of the PS content and the amount of free saccharide in the final formulations measure the potency of the vaccine.
In 2011 the first International Standard for meningococcal serogroup C polysaccharide was established for use in quantification assays for polysaccharide MenC based vaccines. The MenA and MenX candidate materials are designed to be utilized in a similar way as this standard and aim to improve harmonization of polysaccharide content of meningococcal vaccines of which they are components. As both MenA and MenX PS contain a single phosphorus ion per residue, the amount of phosphorus can be used to estimate the concentration of the polysaccharides. It was therefore decided to run the two studies in parallel.
MenA PS consists of N-acetylmannosamine-6-phosphate residues linked by α1-6 phosphodiester bonds and contains about 80% of O-acetylation in position C 3 while position C 4 is only slightly O-acetylated [5] . MenX PS is composed of repeating units of N-acetylglucosamine-4-phosphate residues linked by α1-4 phosphodiester bonds, but without O-acetyl groups [5] . Determination of the phosphorus content of both the final vaccines and bulk components using colorimetric assays is one of the most commonly used methods to quantify the MenA PS [6] . Other methods include high performance (or high pH) anion exchange chromatography-pulsed amperometric detection (HPAEC-PAD), nuclear magnetic resonance spectrometry (NMR) and immunological assays.
NIBSC proposed the production of a MenA and a MenX PS International Standard which were endorsed at the ECBS meeting in October 2013 and October 2014 respectively. These reference preparations, containing a determined quantity of PS could be used to cross-calibrate various methods to quantify the MenA/MenX (MenA and MenX) content of the bulk saccharide, bulk conjugate and final formulations and should be made available under the auspices of WHO to facilitate calibration of assays and in-house reference materials. The continuing and rapid development of new meningococcal conjugate vaccines and multivalent vaccines including
MenA and MenX PS as components, the establishment of programmes to distribute MenA and potentially MenX vaccines throughout the world, and the likelihood that more NCLs will establish methods to evaluate these vaccines indicate that a standard for the quantification of MenA and MenX PS will be important to establish and will be in demand.
WHO guidelines state that for an International Standard to be adopted using Système
International d'Unités (SI) unitage rather than International Units, the assignment should follow ISO 17511 standard principles, if possible. In particular, uncertainty should be assigned and unit assignment should not be based on a bioassay but rather should be derived from and traceable to a physicochemical method. Previously the assignment of unitage to polysaccharide standards developed by NIBSC was calculated from results of multiple laboratories running a single method, and the uncertainty incorporated the combined uncertainty from the different determinations [7] [8] [9] . Following the use of secondary comparative methods to assign a value to MenC and Hib polysaccharide standards, it was proposed that quantitative NMR (qNMR) would be used to determine the PS content of MenA and MenX candidate standards [10] . Quantitative NMR is a potential primary method for quantifying organic compounds [11, 12] and was considered to be the most appropriate method to use to assign unitage. The unitage of the standard is proposed in SI units milligrams (mg), in accordance with both the MenC IS and the measurement and specification of PS in g units in all meningococcal vaccines, plain polysaccharide or conjugate.
Participants
Eleven laboratories from nine countries participated in the study including 5 NCLs, 5 manufacturers and one Pharmacopoeia laboratory. The list of participants is included in the Annex 1 as the MenA/X IS Working Group. Participants were assigned a random code number, not corresponding to the order of listing.
Materials and Methods
The candidate standard samples by the HPAEC-PAD method, using an in-house standard. HPLC sizing was performed on all stability samples using the TSK 6000-5000 PWXL column series, using 50 µg injections into PBS 'A', pH 7.4, run at 0.25 ml/min. The percent eluting by a distribution coefficient (K D ) of 0.35 was calculated. pH and osmolarity were measured for 3 month samples only.
Both the water and NaCl formulation had a similar stability by the characteristics measured. The molecular sizing chromatogram, however, showed a high molecular weight peak in the saline sample possibly showing a change in association of the N-acetylmannosamine-6-phosphate due to its association with NaCl at the time of lyophilisation. The pH of this standard was 0.3 pH units lower; a correlation was found between acidity and depolymerisation. Thus it was decided to use water as the diluent for the definitive fill of the candidate MenA PS.
The MenX PS was dissolved in either water or 15 mM NaCl. As the CaCl 2 was unsuccessful for the MenA PS, this diluent was not evaluated for MenX PS. Both formulations formed good pellets following lyophilisation and were put into ATD studies for 3 months and stored as determined by HPAEC-PAD, using an in house method adapted for MenX saccharide analysis.
Depolymerisation was performed in 1 M HCl, at 100C and samples were diluted 50 times to approximately 20 µg/ml (assuming 1 mg/ampoule) and 50 µl of sample injected on a PA-1
column. An in house MenX PS standard was used to calculate the concentration of the standard using spiked fucose as internal standard for detector normalization.
The water and NaCl formulations had very similar stability by the characteristics measured and the degradation observed in the 37 o C and 56 o C samples in both formulations were very similar.
The pattern of pH change was slightly different between the samples at 3 months.
For the MenX water was also chosen as the diluent on the basis that NaCl did not improve the stability of the MenX PS, and as calcium is already present in the PS, addition of a second counterion would have added to the complexity of the material. For both PSs, residual calcium from purification is the counter-cation.
WHO recommendations for the preparation, characterization and establishment of reference standards were followed for the candidate materials [14] . The processed material was thawed and diluted in sterile distilled water to give a concentration of approximately 1.0 mg MenA/X PS/ml and glass ampoules were filled with 1.0 g of the stock solution at the Centre for Biological
Reference Materials (CBRM), NIBSC details of the filling and freeze drying are in Table 2 .
When the PS standards are reconstituted with 1 ml sterile distilled water, the MenA PS has a pH of 6.4-6.9 and the MenX PS has a pH of 6.9-7.2. 3000 ampoules of 13/246 vials and 856 vials of 
Study materials
Following the invitation to potential participants it was noted that there were three levels of participation which would take place: 
Assigning functional weight to MenA and MenX PS
During the study laboratories 5, 6, 9 and 11 determined the degree of O-acetylation of the MenA PS by NMR methods using 500MHz, 400MHz, 700MHz and 500MHz respectively ( Table 3 ). 
Study design
Participants were requested to perform the assays twice, with fresh ampoules on separate days using the laboratory's own method and standards. A value of 0.5-3 mg for the content of the preparations was provided to participants as a guideline to help in preparation of dilutions. The assay methods performed by the participants are detailed below. All of the 11 laboratories except for one (Lab 8) participated in previous collaborative studies for assignment of unitage to polysaccharide standards.
Assays for evaluation of the candidate standards

Quantitative 1 H-NMR
The 1 H NMR spectrum contains signals arising from specific hydrogen atoms in the structure of the sample [17] ; integration of such signals, where they are well resolved, allows the estimation of the molar concentration of the sample, especially when compared with an internal standard of accurately known concentration. In total five laboratories performed qNMR (5, 6, 8, 9 and 11) using in-house methods the experimental parameters of which are summarised in Table 3 . Lemercinier [16] . Details are in Table 5 .
NIBSC Method
For the MenX, 700 µl of sample was transferred to labelled 535-PP NMR tubes and placed on the automation rack on the NMR spectrometer. was performed on each sample using specific optimised parameters for MenA PS or MenX PS (Table 4 ). For MenA, NMR spectra were acquired at 303K, 128 scans collected into 65K data points with a spectral width of 15 ppm, a 10 msec mixing time and a relaxation delay of 39.6 sec.
For MenX, NMR spectra were acquired at 303K, 256 scans collected into 65K data points with a spectral width of 15 ppm, a 10 msec mixing time and a relaxation delay of 10.2 sec.
The resolution of the acquired MenX spectra was broad and the shimming was poor resulting from fine particulates in solution. The samples were transferred to labelled Eppendorf vials and spun for 30 min to remove particulates. A volume of 600 µl was then transferred to labelled 535-PP NMR tubes and placed on the automation rack on the NMR spectrometer. The 1D NOESY experiment was re-run using the same parameters.
Phosphorus Assays
Nine laboratories (1, 2, 3, 5, 6, 7, 8, 9 and 10) ran phosphorus assays to determine the MenA/MenX content of the candidate materials. They all performed a colorimetric assay and in addition, Labs 8 and 9, also measured phosphorus by an Inductively Coupled Plasma (ICP) emission method.
In the colorimetric Chen method [6] , the PS candidate material and in-house phosphorus standards of known quantity are mixed with sulfuric acid, ammonium molybdate and ascorbic acid. Phosphomolybdate is formed which is further reduced by the ascorbic acid to form a blue coloured complex. The absorbance of the samples is measured and is directly proportional to the phosphorus content of the standards. Four laboratories used a liquid phosphorus standard solution for phosphorus determination. Five laboratories used sodium or potassium phosphate salt forms which were weighed. Lab 8 and 9 also used specific liquid phosphorus standard for ICP-OES and ICP-MS. All standards were diluted in water. Further details from laboratories performing phosphorus assays are included in Table 5 . 
HPAEC-PAD
Two laboratories performed HPAEC-PAD (9 and 11). For PS depolymerization prior to chromatography, both laboratories used TFA hydrolysis for MenA PS [18] and HCl hydrolysis for MenX PS. This acid hydrolysis approach is used to measure the content of the de-O and de-N-acetylated saccharide repeating units, mannosamine-6-phosphate or glucosamine/glucosamine-4-phosphate for MenA and MenX, respectively. If MenA or MenX PS is used as a standard (both laboratories for MenA), the PS content can be directly measured.
Laboratory 9 used D-(+) glucosamine hydrochloride as a standard in the MenX assay and the results therefore required a conversion factor. The laboratories used CarboPac PA10 or PA1 columns, and resolved the relevant peaks from the internal standards using an eluent containing around 200mM NaOH and 100 to 200 mM sodium acetate. Further details from laboratories performing the HPAEC-PAD assay are included in Table 6 . Besides the standards used, the only notable difference was the hydrolysis conditions used for MenX PS: Lab 9 used a harsh hydrolysis for MenX compared to Lab 11 [2] .
Nephelometry
One laboratory returned results for MenA PS only using rate nephelometry (Lab 4). The method relies on formation of antigen-antibody aggregates which are detected via light scattering. The rate at which the complex forms is directly related to the amount of antigen (PS) in the sample. A value for the content of the ampoules and the bulk conjugate was determined from a standard curve generated from purified polysaccharide of known concentrations.
ELISA
An ELISA assay was carried out to determine MenA content of 13/246 by one laboratory (Lab 5)
using an in-house MenA PS standard as standard. The method employed was a capture or sandwich ELISA. Anti-MenA PS monoclonal antibodies (mAbs) were used to coat an ELISA plate. The test samples were added to the wells and the MenA PS captured by the bound mAbs.
A secondary antibody, anti-MenA mAb conjugated to peroxidase, was added followed by its substrate, resulting in a visible colour change. The intensity of the colorimetric signal detected is proportional to the amount of polysaccharide in the sample and a value determined for the samples from a standard curve generated from samples of known MenA PS concentration in the assay.
Stability Studies
To determine the stability of the candidate MenA and MenX PS standards, three studies of the were analysed in a single session.
In the final study, the candidate standards were reconstituted in 1 ml of sterile distilled water and The MenA PS content was determined using high performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) method with a CarboPac PA-1 analytical
column. An in-house MenA polysaccharide was used as a quantitative standard (0.5-27 µg/ml), and glucosamine-1-phosphate (Sigma) at 4 µg/ml as an internal spike for normalization. For the quantitative analysis, samples and standards were subjected to acid hydrolysis with 2.0 M TFA, for 2 h at 100 o C. The eluents were mixed with a gradient pump to achieve 0-12 min, 100 mM NaOH; 12-35 min, 100 mM NaOH, 100-224 mM NaOAc (sodium acetate); and, 35-45 min, 400 mM NaOH. The column was then re-equilibrated with the starting eluent (100 mM NaOH) for 10 min. The flow rate was 1 ml/min. The content of MenA was determined by integrating the peak arising from N-acetyl mannosamine relative to the standard curve, with signal normalized by the internal spike.
The MenX PS content was determined using the HPAEC-PAD method with the following alternation from the MenA method. An in-house MenX polysaccharide was used as a quantitative standard (0.5-27 µg/ml), and with L-Fucose (Sigma) at 4 µg/ml as an internal spike.
Samples and standards were subjected to acid hydrolysis with 1.0 M HCl, for 2.5 h at 100 o C. The eluents were mixed to achieve 0-13 min, 50 mM NaOH; 13-25 min, 50 mM NaOH, 100-224 mM NaOAc; and, 25-35 min, 400 mM NaOH. The column was then re-equilibrated with the starting eluent. The content of MenX was determined by integrating the peak arising from N-acetyl glucosamine relative to a standard curve, using the peak area of the internal spike for signal normalization.
Molecular sizing analysis was performed using a Dionex DX-600 HPLC system with Tosoh
Bioscience TSK gel G6000 + 5000 PWXL columns in series preceded by a PWXL guard column.
The mobile phase was phosphate buffered saline 'A' pH 7.4 at a flow rate of 0.25 ml/min (0.3 ml/min for MenX). The void and total column volumes were determined using salmon DNA (Sigma) and tyrosine (Sigma), which eluted at 45 min and 100 min respectively (40 min and 83 min for MenX). The 214 nm signal (Dionex VWD multi-wavelength UV Detector) was used for determining the % eluting at a distribution coefficient (K D ) of 0.37 for both MenA and MenX.
Conversion Factors
The determination of the amount of MenA or MenX PS from the estimated phosphorus concentration relies on a conversion factor. This factor takes into account the proportion of the total functional mass of a PS residue which is contributed by phosphorus. In the case of MenA PS the functional weight of the residue varies depending on the acetylation status which can differ from batch to batch in vaccine production. The MenX PS is not O-acetylated, however, the conversion factors used by participants were still different. In the case of MenA these varied from 10.204-12.500 and MenX from 9.174-9.840 (Table 5 ). For this study the results in part 1
were re-converted from the phosphorus values using the NIBSC conversion factors of 10.897 for MenA and 9.757 for MenX. In part 2 laboratories were asked to report values using in-house reference material; two laboratories reported the estimation in mg of PS per ml but the majority reported the phosphorus content. For this reason all results were converted using NIBSC conversion factors to give a final result. The mean MenA PS per ampoule was calculated to be 882 μg PS per ampoule with a relative standard uncertainty of 1.37% (Tables 8-10 ).
Results
MenX PS
The 1 H-NMR assignment and interpretation of Men X has been published [2] . Two resonances 
14/156 by participating laboratories
Details of all the data from the collaborating laboratories for estimation of the quantity of MenA/MenX PS per ampoule is summarised in Table 13 and Figure 3 .
Quantitative 1 H-NMR
Five laboratories returned qNMR data summarised in Table 13 . Overall there was fairly good agreement between the laboratories with the exception of laboratory 8 whose data were excluded from further analysis. The use of excessive maleic acid as the internal standard may account for this as the acid could hydrolyse the candidate material, although it is noted that laboratory 6 also used maleic acid as an internal standard, but at a much lower concentration. Two of the MenA PS ampoules evaluated in laboratory 9 gave much lower values than the other two, and it was thought that this was due to loss of material. The use of TSP as a reference gave slightly higher values than obtained using caffeine as a reference.
The estimated mean value of the content of candidate material MenA PS 13/246 by qNMR across four laboratories is 0.828 mg per ampoule with a CV of 6.8%. Combining the relative standard uncertainty determined at NIBSC (Table 10) The values of MenX determined by the HPAEC-PAD method were dependent on the hydrolysis method used for depolymerization. The harsh hydrolysis method of laboratory 9 appeared to cause destruction of the glucosamine that was being measured, as the values obtained were the lowest from any method.
HPAEC-PAD
Aside from this result, it is apparent that the methods that relied on depolymerization of MenX saccharide, namely the phosphorus and HPAEC-PAD methods, did give slightly higher results than were obtained by qNMR alone.
Nephelometry
The nephelometry result from laboratory 4 for the MenA content of 13/246 was estimated as 1.13 mg/ ampoule, this estimate is above the upper limit of the proposed value.
ELISA
The ELISA result from laboratory 4 for the MenA content of 13/246 was estimated as 0.877 mg/ ampoule, which falls within the expanded uncertainty of the proposed unitage.
Part 2. Determination of MenA and MenX saccharide in bulk conjugate samples
The purpose of part 2 was to determine if the candidate standards could be used to accurately determine the MenA and MenX saccharide content in vaccine samples. This is demonstrated by comparing the saccharide content values determined across laboratories when the candidate standard is used compared to the in-house standards. Laboratory mean estimates (mg MenA or MenX saccharide/ml) obtained for the bulk conjugate sample are summarized in Table 14 .
Participants were asked to assume a value of 1 mg/ampoule for the candidate standards, however the data have been converted on the basis of the standards containing 0.828 mg/ ampoule (MenA) and 0.775 mg/ ampoule (MenX).
The use of the MenA PS candidate standard decreased the mean value by approximately 15% to 0.628 mg/ml compared to 0.740 mg/ml determined from in-house phosphate or liquid phosphorus standards in the phosphorus assays. The % C.V. was decreased by 6% when using the candidate standard, although the spread of data was still wide. This appears to be due to higher estimations from laboratory 2, and laboratory 8, who used an ICP method, as well as individual assay biases, rather than any particular trend from the assays themselves. Two laboratories returned incomplete data sets for part two. Laboratory 8 and 10 returned data for the estimation of the PS content of the bulk conjugate using their in-house standard but not the candidate material. The estimations from laboratory 8 are relatively high it is possible that this could bias the average value (0.740mg/ml) calculated from all laboratory data using in-house reference material. If the data from laboratories 8 and 10 are excluded the mean value estimate using in-house standards is 0.682mg/ml, 8% higher than estimated using the candidate material.
The most improvement in variability came with the use of the MenA candidate standard in the HPAEC-PAD assay, with a concentration of 0.509 mg/ml using the candidate or 0.628 mg/ml using in-house standards. For this assay, the use of the common standard reduced variability from 15.8% C.V. to 3.9% C.V.
The values determined by rate nephelometry decreased using the candidate standards by approximately 3%; however results from this method were twice as high as determined by HPAEC-PAD, and the highest of any method.
Similar observations were found for the determination of MenX saccharide by phosphorus assays. A difference in the average MenX saccharide content of approximately 17% was determined when using a common polysaccharide (0.514 mg/ml) compared with using in-house chemical standards (0.616 mg/ml). If the data from laboratories 8 and 10 is removed, as explained above, from the estimation of the MenX content of the bulk conjugate using the in house reference material the mean estimation is 0.542mg/ml reducing the difference between the two estimated values to 5%.
The HPAEC-PAD assay showed an improvement from the use of the candidate standard, and this was particularly noted in the results from lab 9, where the use of a harsher hydrolysis method gave very low values when the in-house standard was used.
Regardless of the method, use of the candidate International Standards resulted in lower estimation of the content of the bulk conjugate material.
Stability of the candidate MenA and MenX polysaccharide standards
The amount of MenA PS in an ampoule was compared over time using the HPAEC-PAD assay in the three stability studies: real-time, accelerated thermal degradation and reconstituted. The amount of PS in the -20 o C baseline ampoule remained constant (within 6%) for up to 12 months (Table 15 ). In the accelerated thermal degradation study, samples stored up to +56°C for 12 months showed no temperature-related trend in the MenA content (Table 15 ). Due to its stability, it was not possible to predict a percentage loss of MenA content per year. The MenA content also remained constant following reconstitution up to 8 weeks (Table 16 ). The amount of MenX PS in an ampoule was compared over time using the HPAEC-PAD assay in the three stability studies: real-time, accelerated thermal degradation and reconstituted. In the accelerated thermal degradation study samples stored at +56°C showed a small decreasing trend in MenX content (Table 17 ). The MenX content remained constant (within 8%) following reconstitution up to 4 weeks but decreased by 28% after 8 weeks (Table 18 ). This may have been due to poor mixing of the sample, as sizing chromatography does not indicate degradation of the real-time sample up to 6 months. An additional reconstituted stability study will be set up to evaluate the stability of the reconstituted samples. As no laboratory has the required accreditation to assign a value to the material as described above there was no valid reason (with the exception of the data from laboratory 8) to exclude any of the qNMR data and the result from each laboratory was given equal weighting to assign a final value to the contents of the MenA and MenX polysaccharides.
Previous assignments of the quantity of polysaccharide in ampoules by NIBSC have used the most common assay in the study, in the case of MenC the resorcinol assay and for Hib the ribose assay. However, as the unitage assigned is SI units the use of secondary assays is not recommended. Therefore to improve the accuracy of the value assigned and reduce the uncertainty qNMR has been selected for the proposed unitage of the standards. As qNMR returned a lower estimate for the material than the phosphorus assays of approximately 10% it is not surprising that the use of this standard also gives lower polysaccharide content estimations for the bulk vaccine material. Therefore if vaccine manufacturers use the candidate material they are likely to see a reduction in the total polysaccharide estimates. This will need careful consideration for those with established products with proven efficacy. However, scientifically the investigators on this project would argue that the use of the assignment of unitage by qNMR is the most appropriate of the methods.
Suitability of the candidate standards
The candidate materials were assessed in part 2 of the study for their suitability to use in established methods across the laboratories worldwide. The results from this study suggest that the candidate materials can be used to estimate the amount of polysaccharide in final vaccines and vaccine bulk components. In the assays used in the study, phosphorus (Chen and ICP), HPAEC-PAD, rate nephelometry and ELISA, a dose response was seen and a standard curve was generated from which the polysaccharide content of unknown material could be determined.
In the case of HPAEC-PAD the between-laboratory comparability was improved. Standard for meningococcal serogroup C polysaccharide also had their unitage assigned in mg/ampoule [8, 9] .
Stability and Storage of the candidate standards
While the content has been assigned based on quantitative NMR assays, the material is potentially suitable for use in the quantitation of MenA and MenX content by other assays.
However all assays gave a lower result for polysaccharide content of a bulk conjugate when using the candidate International Standards as compared to in-house standards. This is the first use of quantitative NMR for assignment of unitage as it is a non-destructive method, while the phosphorus and HPAEC-PAD methods are destructive methods, and the ELISA and nephelometry methods rely on polysaccharide integrity or antibody binding. Previously, the Hib and MenC polysaccharide standards had their unitage based on spectrophotometric methods, with unitage traceable to ribose or sialic acid references. In all of these cases, including NMR, it is the weight of the reference that defines the measurement, rather than a physical parameter, which is what defines an absolute method. The results obtained by the phosphorus assays are, in both cases, higher than that determined by qNMR, and this is likely to be due to moisture content that has not been measured. The standard's unitage will be traceable to the reference materials used for qNMR. Due to the limited number of labs performing the HPAEC-PAD, ELISA and nephelometry, it has not been possible to determine the reason for the differences in the individual means from these assays.
Participants Comments
A draft version of this report was sent to all participants for comment and to confirm if each agreed with the recommendation. 10 of the 11 laboratories replied. No response (1 lab) was taken as acceptance of the proposal. All 11 laboratories agreed with the proposal.
Relevant comments and our reply are given below: We currently do not have any statistical or scientific reason to exclude these results however we are concerned that they are low. We plan to ask the laboratory if they would be willing to run more samples to provide more data as to whether the two results are outliers. It may then be possible to submit an addendum to ECBS prior to the decision as to whether or not no establish the candidates as International Standards.
The data provided in table 14 do indicate a strong spread and a relatively important bias as compared to non-conjugated samples. Isn't that indicative that the reference should not be recommended for conjugates analysis?
"The spread of the determinations of saccharide content for the bulk conjugates is due mainly to the inclusion of methods that are under development, such as ICP and HPAEC-PAD (for MenX). The standards are suitable for use for determining the saccharide content of bulk conjugates using the phosphorus determination and HPAEC-Pad methods. The rate nephalometry method gave comparatively higher results, but this is due to the method factors, rather than the use of a PS standard." The report will contain a statement saying that the use of the standard should be validated for individual assays in each laboratory.
It would be interesting to report on the number of replicates that were performed per time point.
We are investigating within GSK on the best design for the stability monitoring of reference material and have developed some stat approaches to ensure robust determination of the stability profiles in that context, as the limits to consider should be tighter than for a regular commercial vaccines.
Due to the length of the HPLC-SEC runs, a single or 2 replicate injections were made from a single sample. For the HPAEC-PAD, two replicate injections were made from a single sample.
I was wondering whether the use of HPEAC-PAD assay for stability monitoring was appropriate as it relies on a hydrolysis of the sample before content determination.
For real-time studies, the use of HPAEC-PAD is certainly justified. Both the phosphorus and the HPAEC-Pad rely on hydrolysis. For the MenA and MenX PS, up to the periods reported, we did not see the same discrimination between saccharide contents of samples kept at 37 or 56 C, as we did for the MenC PS, as discussed in the Biologicals paper. For the 1 st Hib, we did not see an effect, and for the 2 nd Hib, we used only the orcinol assay for the stability study, due to resource constraints. We agree that it is necessary to monitor the effect of heavy degradation on the degree of depolymerization of standard and sample from different methods. Between-ampoule standard uncertainty = 100.02 = 10.00
Standard error (random) = (95.70 / 5) = 4.37 NMR values from 9a were determined using caffeine as a reference, and from 9b, using TSP as a reference.
Phosphorus values from Labs 8i and 9i were determined using an ICP method.
HPAEC-PAD values from Lab 11a and 11b were determined using different in-house MenA PS standards.
For those values which required conversion factors such as the phosphorus assay-determined values, harmonised conversion factors were used as described in the section, Assigning functional weight to MenA and MenX PS. Where participants had applied in-house conversion factors, de-converted values were used. Phosphorus values from Labs 8i and 9i were determined using an ICP method.
HPAEC-PAD values from Lab 11a and 11b were determined using different in-house MenA PS standards. b.
